Component Resolved Diagnostics

Slides:



Advertisements
Similar presentations
Egg Allergy Important food allergy in children Starts early in life
Advertisements

Peanut Allergy 10% of children are sensitized but only 1-2% have symptoms Usually life-long Symptoms range from local reactions to anaphylaxis Very small.
Food Allergy Update Thomas Flaim, M.D.. Prevalence of Food Allergy Prevalence rate is 6% in children < 3 years of age; 4% in adults Prevalence rate is.
1 Oral Immunotherapy Wesley Burks, M.D. Professor and Chair Department of Pediatrics University of North Carolina.
ImmunoCAP ISAC Customer days
Bischenberg, 23 rd September 2007The GA 2 LEN/EAACI Allergy School Effects of heat treatment and proteolytic enzymes on allergenicity Dr. Montserrat Fernández.
Common Food Sensitivities, Allergens, and Intolerances
Food Allergy Highlights of the past 3 years Adam Fox Paediatric Study Day Cheltenham June 2004 Dr Adam Fox.
Literature support Test chart for the use of ImmunoCAP ® Allergen components Suspicion of fruit allergy Risk for severe reactions?
Soy Allergy Important protein source Sensitization frequency varies largely Prevalence of soy allergy % Symptoms –cuteaneous or gastrointestinal.
Asthma & Allergies: Current Trends & Relationship to Housing Prof Anthony Frew Allergy & Respiratory Medicine University of Southampton
Literature support Test chart for the use of ImmunoCAP® Allergen components Suspicion of peanut allergy Risk for severe reactions?
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
Literature support Test chart for the use of ImmunoCAP® Allergen components Suspicion of egg allergy Risk for clinical reactions?
Introduction to Food Allergens
HYPERSENSTIVITY Hypresensitivity causes reproducible symptoms and sings initiated by exposure to defined stimulus that is tolerated by „normal” people.
Allergen regulation in the future : what will be the place for recombinant allergens ? Jacqueline DAYAN-KENIGSBERG European Academy of Allergology and.
Allergenicity assessment of genetically modified organisms (GMOs )
Microarrays for allergy
T-cell Immunoregulation and the Response to Immunotherapy Harold S. Nelson. MD Professor of Medicine National Jewish Health and University of Colorado.
ISAC and Component-resolved Diagnosis
Historical overview Pr G. Pauli Hôpitaux Universitaires de Strasbourg Bischenberg 21 septembre 2007.
By: Cecilie Braadt. Overview  My Story  What is a Food Allergy?  The Top Food Allergens  Development of a Food Allergy  Signs and Symptoms  Reducing.
Food Allergies: Advances in Diagnosis and Management Greg Black, MD
Childhood allergies and childhood allergy medicine
Prevalence of Asthma, Rhinitis and Eczema in Saudi Arabia * Physicians’ diagnosed Asthma + highly suspected asthma * * 1986: n=2123, 1995: n=1008, 2001:n=1014.
Hypersensitivity Type III and IV. Classification of Hypersensitivity TypeMechanismExample I IgE mediatedSystemic anaphylaxis eg peanut allergy Asthma.
Catherine M. Bettcher, M.D. CME Director & Assistant Professor, Department of Family Medicine, University of Michigan No Nuts Allowed: Food Allergies in.
Food Allergies in Children
ALERBLOT: Interest of 2D Immunoblot in diagnosis of wheat allergy
Le allergie alimentari multiple
Suggested IgE ab testing of suspected soy allergic patients
Sensitization profile in a group of Spanish patients allergic to LTP
(SHRIMP SENSITIZED ON AIT) 5 failed OFC + 5 w/ hx of anaphylaxis
Will genetically modified foods be allergenic?
Selecting Allergen for BAT
Outline 1.What is the link between food allergy and asthma development? 2. What routes of exposure to food should be considered in evaluating suspected.
a growing food allergy in adults
The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy  Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.
Identification of sesame seed allergens by 2-dimensional proteomics and Edman sequencing: Seed storage proteins as common food allergens  Kirsten Beyer,
Food Allergies: Diagnosis & Management
62 Patients with positive sIgE f13 or n n= 38 (f13), n=24 (f17)
Allergy diagnosis for inhalant immunotherapy
Statistical Considerations of Food Allergy Prevention Studies
Allergy Testing in Children
Eosinophilic gastrointestinal disease suggestive of pathogenesis-related class 10 (PR- 10) protein allergy resolved after immunotherapy  Liliane De Swert,
Margaretha A. Faber, MD, PhD, Athina L. Van Gasse, MD, Ine I
Cow's milk epicutaneous immunotherapy in children: A pilot trial of safety, acceptability, and impact on allergic reactivity  Christophe Dupont, MD, PhD,
Food Allergies: The Basics
Food Allergy: Common Causes, Diagnosis, and Treatment
Figure 2 Approach to diagnosis and management of food allergy
Advances in Peanut Allergen Immunotherapy
Heimo Breiteneder, PhD, Christof Ebner, MD 
Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults  Christian Lupinek, MD,
Allergy testing in predicting outcome of open food challenge to peanut
Prediction of peanut allergy in adolescence by early childhood storage protein-specific IgE signatures: The BAMSE population-based birth cohort  Anna.
Rhinitis and asthma: Evidence for respiratory system integration
Component-Resolved Diagnosis (CRD) of Type I Allergy with Recombinant Grass and Tree Pollen Allergens by Skin Testing  Susanne Heiss, Rudolf Valenta 
Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1– related PR-10 protein in soybean, SAM22  Jörg Kleine-Tebbe, MDa, Andrea Wangorsch,
Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy  Katharina Blumchen, MD,
Songhui Ma, MD, Scott H Sicherer, MD, Anna Nowak-Wegrzyn, MD 
Prevalence of Asthma, Rhinitis and Eczema in Saudi Arabia * Physicians’ diagnosed Asthma + highly suspected asthma * 1986: n=2123, 1995: n=1008, 2001:n=1014.
Clinical cross-reactivity among foods of the Rosaceae family
Advances in the approach to the patient with food allergy
Will genetically modified foods be allergenic?
Thomas A. E. Platts-Mills, MD, PhD, Richard B. Sporik, MD, Lisa M
Peanut oral immunotherapy decreases IgE to Ara h 2 and Ara h 6 but does not enhance sensitization to cross-reactive allergens  Riikka Uotila, MD, Anna.
Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence  Marit Westman, MD, Christian Lupinek,
In vitro assays for the diagnosis of IgE-mediated disorders
Presentation transcript:

Component Resolved Diagnostics Roisin Fitzsimons Consultant Nurse Guy’s and St Thomas NHS Foundation Trust

Overview of session Current diagnostic methods What is component resolved diagnostics (CRD)? Application to practice

Allergy Diagnosis History Skin Prick Testing (SPT) Specific IgE Testing (SpIgE) Provocation - Oral food challenge

What is CRD?

Protein Formation

Major peanut allergens Peanut components Ara h 2 Ara h 1 Ara h 8 Ara h 9 Ara h 3 Major peanut allergens

Features of peanut components Seed storage proteins PR10 proteins Lipid Transfer Proteins (LTP) Ara h 1,2,3 - major peanut allergens Ara h 8 Ara h 9 Responsible for primary sensitisation Recognition of similar structures Found in nuts, seeds, legumes Bet v 1 homologue (Apple Mal d 1) Heat resistant and stable May cause systemic, severe reactions Altered by heating/gastric juices Risk of severe reactions Not easily broken down Localised symptoms Cross-reactivity with Pru p 3 Present in large quantities Pollen food syndrome Common in Southern European countries Can we predict severity of allergy? Formed of components Structure and significance varies

Relevance to practice Can we predict severity of a reaction? Ara h 1,2,3 – primary sensitisation to peanut Ara h 8 – cross reactivity with Birch pollen

Case study - Rose 8 year old Sesame allergic Allergic Rhinitis FH peanut allergy Always avoided peanuts Immunological investigations SPT 2mm SpIgE 4.38ku/ml Ara h 1 – 0.00 Ara h 2 – 0.16 Ara h 3 – 0.00 Ara h 8 – 6.24

What next? Allergic; avoid peanuts? Tolerant; introduce peanuts? Probably OAS; introduce peanuts with caution? Not sure; OFC?

Proceeded to OFC Tolerated first two doses Third dose – oral pruritus, no objective symptoms Repeated dose – worsening of pruritus, not distractible What next?

Implications for practice Ara h 2 clinically relevant for predicting positive OFC Presence of Ara h 1&3 increases likelihood of allergy Ara h 8 may suggest OAS Listen to your patient and family

Summary CRD useful in aiding diagnosis Should not replace clinical history and holistic evaluation Easier to predict allergy than tolerance

Reference list Beyer K et al 2015, Allergy; 70: 90–98. Dang T D et al, 2012, J Allergy Clin Immunol;129:1056-63 Nicolaou N et al, 2010, J Allergy Clin Immunol; 125:191-7 Asarnoj A and Movérare R et al, 2010, Allergy